Spotlight
Memorials
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
What travelers need to know about the government shutdown
Recommended
In Depth with Dan: Beachfront homes collapse in NC's Outer Banks, converting garbage into energy
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Apollomics, Inc.
Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium
April 11, 2023
From
Apollomics, Inc.
Via
GlobeNewswire
Tickers
APLM
APLMW
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
March 30, 2023
From
Apollomics, Inc.
Via
GlobeNewswire
Tickers
JMAC
Apollomics Announces Completion of Business Combination and Listing on Nasdaq
March 29, 2023
From
Apollomics, Inc.
Via
ACN Newswire
Tickers
JMAC
JMACU
Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations
November 15, 2022
From
Apollomics, Inc.
Via
GlobeNewswire
Tickers
JMAC
JMACU
JMACW
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
July 26, 2022
From
Apollomics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.